Drugs / epidoxorubicine
last change Dec 2007 re-read 2 minutes ago

epidoxorubicine

Developed for
breast neoplasm

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00174707 Comparator Dec 1997 → Dec 2007 breast neoplasm Sanofi Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as epidoxorubicine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00174707